Could targeting T-helper cells aid the development of effective cancer vaccines?

Selective antigen-specific CD4+T-cell, but not CD8+T- or B-cell, tolerance corrupts cancer immunotherapy

(2014) Adam E. Snook et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

T-Cell Tolerance: Central and Peripheral

(2012) Y. Xing et al.   Cold Spring Harbor Perspectives in Biology

GUCY2C-targeted cancer immunotherapy: past, present and future

(2011) Adam E. Snook et al.   IMMUNOLOGIC RESEARCH

A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides

(2011) Linda Wooldridge et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic variation, Fcγ receptors, KIRs and infection: the evolution of autoimmunity

(2010) Marion Espeli et al.   CURRENT OPINION IN IMMUNOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lineage-Specific T-Cell Responses to Cancer Mucosa Antigen Oppose Systemic Metastases without Mucosal Inflammatory Disease

(2009) A. E. Snook et al.   CANCER RESEARCH

Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

(2008) Adam E. Snook et al.   JNCI-Journal of the National Cancer Institute